Location: RM 271
BILL SUMMARY for Bill Discussion - Bill 3
OPIOID AND OTHER SUBSTANCE USE DISORDERS
|Votes: View-->||Action Taken:|
03:46 PM -- Bill Discussion - Bill 3
Christy Chase, representing the Office of Legislative Legal Services, explained Bill 3 to the committee (Attachment U). The bill:
- excludes supervised injection facilities from the laws regarding public nuisance;
- allows local public health agencies to establish clean syringe exchange programs without prior approval from their governing health boards and grants civil immunity to a person who provides a clean syringe in accordance with a clean syringe exchange program;
- specifies that hospitals may be used as clean syringe exchange sites;
- allows school districts and nonpublic schools to develop a policy by which schools are allowed to obtain a supply of opiate antagonists and school employees are trained to administer opiate antagonists to individuals at risk of experiencing a drug overdose; and
- increases the criminal penalties related to synthetic opioids.
04:13 PM -- Adeline Hodge, representing the Colorado Association of School Nurses, the Colorado Providers Association, and the Colorado Association of Local Public Health Officials, testified in a neutral capacity.
04:17 PM -- Maureen Cain, representing the Colorado State Public Defender's Office, testified in a neutral capacity.
04:30 PM -- Christie Donner, representing Colorado Criminal Justice Reform Coalition, testified in a neutral capacity.
Dr. Valuck testified in support of Bill 5 and Bill 6. He expressed that there is a significant need for in patient treatment.
04:38 PM -- Lisa Raville, representing the Harm Reduction Action Center, testified in support of supervised injection facilities and presented a handout (Attachment V). Ms. Raville answered questions from committee members about concerns regarding supervised injection sites.
04:56 PM -- Heidi Schlossberg, representing herself, testified in a neutral capacity.
04:57 PM -- Angela Bonaguidi, representing the Colorado Organization for the Treatment of Opioid Dependence, testified in a neutral capacity and distributed a handout (Attachment W).
04:59 PM -- Jamie Feld, representing Boulder County Public Health, testified in a neutral capacity. Ms. Feld responded to committee questions regarding naloxone in public schools.
05:10 PM -- Meghan Dollar, representing the Colorado Municipal League, testified in a neutral capacity and expressed concern regarding local control of proposed injection sites.
05:12 PM -- Frank Cornelia, representing the Colorado Behavioral Health Council, testified in a neutral capacity. Mr. Cornelia responded to questions from committee members regarding incentives for pursuing treatment and increasing inpatient programs in Colorado.
05:18 PM -- Michael Miller, representing Young People in Recovery, testified in a neutral capacity and expressed support for safe injections sites and other harm reduction measures.